Research ExplorerScientific StaffAndreas Lübke Publications

Dr.med. ID: 48603

Andreas Lübke

graph of relations
Affiliations
51 - 100 out of 111Page size: 50

Publications

  1. 2021

  2. Napsin A Expression in Human Tumors and Normal Tissues

    Weidemann, S., Böhle, J. L., Contreras, H., Luebke, A. M., Kluth, M., Büscheck, F., Hube-Magg, C., Höflmayer, D., Möller, K., Fraune, C., Bernreuther, C., Rink, M., Simon, R., Menz, A., Hinsch, A., Lebok, P., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Burandt, E., Krech, R., Dum, D., Krech, T., Marx, A. & Minner, S., 2021, In: PATHOL ONCOL RES. 27, p. 613099

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2020

  4. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

    Freytag, M., Kluth, M., Bady, E., Hube-Magg, C., Makrypidi-Fraune, G., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Wittmer, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Luebke, A. M., Simon, R., Sauter, G., Schlomm, T. & Möller, K., 18.12.2020, In: BMC CANCER. 20, 1, p. 1220

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

    Möller, K., Wecker, A. L., Höflmayer, D., Fraune, C., Makrypidi-Fraune, G., Hube-Magg, C., Kluth, M., Steurer, S., Clauditz, T. S., Wilczak, W., Simon, R., Sauter, G., Huland, H., Heinzer, H., Haese, A., Schlomm, T., Weidemann, S., Luebke, A. M., Minner, S., Bernreuther, C., Bonk, S. & Marx, A., 11.2020, In: VIRCHOWS ARCH. 477, 5, p. 625-636 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. High B7-H3 expression is linked to increased risk of prostate cancer progression

    Bonk, S., Tasdelen, P., Kluth, M., Hube-Magg, C., Makrypidi-Fraune, G., Möller, K., Höflmayer, D., Dwertmann Rico, S., Büscheck, F., Minner, S., Heinzer, H., Graefen, M., Hinsch, A., Luebke, A. M., Dum, D., Uhlig, R., Schlomm, T., Sauter, G., Simon, R. & Weidemann, S. A., 10.2020, In: PATHOL INT. 70, 10, p. 733-742 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

    Bernreuther, C., Daghigh, F., Möller, K., Hube-Magg, C., Lennartz, M., Lutz, F., Rico, S. D., Fraune, C., Dum, D., Luebke, A. M., Eichenauer, T., Möller-Koop, C., Schlomm, T., Wittmer, C., Huland, H., Heinzer, H., Graefen, M., Haese, A., Burandt, E., Tsourlakis, M. C., Clauditz, T. S., Höflmayer, D., Izbicki, J. R., Simon, R., Sauter, G., Minner, S., Steurer, S. & Meiners, J., 10.2020, In: PATHOL ONCOL RES. 26, 4, p. 2709-2722 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

    Kind, S., Büscheck, F., Höflmayer, D., Hube-Magg, C., Kluth, M., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Weidemann, S., Fraune, C., Beyer, B., Steuber, T., Huland, H., Graefen, M., Fisch, M., Simon, R., Sauter, G., Schlomm, T., Minner, S. & Eichenauer, T., 09.2020, In: WORLD J UROL. 38, 9, p. 2185-2196 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

    Bonk, S., Kluth, M., Jansen, K., Hube-Magg, C., Makrypidi-Fraune, G., Höflmayer, D., Weidemann, S., Möller, K., Uhlig, R., Büscheck, F., Luebke, A. M., Burandt, E., Clauditz, T. S., Steurer, S., Schlomm, T., Huland, H., Heinzer, H., Sauter, G., Simon, R. & Dum, D., 09.2020, In: PROSTATE. 80, 13, p. 1097-1107 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

    Luebke, A. M., Ricken, W., Kluth, M., Hube-Magg, C., Schroeder, C., Büscheck, F., Möller, K., Dum, D., Höflmayer, D., Weidemann, S., Fraune, C., Hinsch, A., Wittmer, C., Schlomm, T., Huland, H., Heinzer, H., Graefen, M., Haese, A., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Meiners, J., 15.07.2020, In: INT J CANCER. 147, 2, p. 575-583 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

    Fraune, C., Yehorov, S., Luebke, A. M., Steurer, S., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Sauter, G., Weidemann, S., Dum, D., Kind, S., Minner, S., Schlomm, T., Huland, H., Heinzer, H., Graefen, M. & Burandt, E., 07.2020, In: PATHOL INT. 70, 7, p. 441-451 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

    Eichenauer, T., Simmendinger, L., Kluth, M., Chirico, V., Luebke, A. M., Höflmayer, D., Hinsch, A., Jacobsen, F., Hube-Magg, C., Möller-Koop, C., Dahlem, R., Fisch, M., Rink, M., Riechardt, S., Tsourlakis, M. C., Büscheck, F., Bernreuther, C., Clauditz, T., Lebok, P., Simon, R., Sauter, G., Wilczak, W. & Fraune, C., 06.2020, In: UROL ONCOL-SEMIN ORI. 38, 6, p. 605.e1-605.e8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

    Eichenauer, T., Federlein, F., Möller, K., Chirico, V., Kind, S., Lennartz, M., Lutz, F., Hube-Magg, C., Höflmayer, D., Fisch, M., Huland, H., Heinzer, H., Graefen, M., Haese, A., Schroeder, C., Lebok, P., Minner, S., Simon, R., Sauter, G., Schlomm, T., Wilczak, W., Steurer, S. & Luebke, A. M., 06.2020, In: PATHOLOGY. 52, 4, p. 421-430 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

    Blessin, N. C., Spriestersbach, P., Li, W., Mandelkow, T., Dum, D., Simon, R., Hube-Magg, C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Nickelsen, V., Fehrle, W., Göbel, C., Weidemann, S., Clauditz, T., Lebok, P., Möller, K., Steurer, S., Izbicki, J. R., Sauter, G., Minner, S., Jacobsen, F., Luebke, A. M., Büscheck, F., Höflmayer, D., Wilczak, W., Burandt, E. & Hinsch, A., 06.2020, In: CELL ONCOL. 43, 3, p. 421-430 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Symptomatic Intraosseous Vascular Malformation of Infraorbital Rim: A Case Report With Literature Survey

    Friedrich, R. E., Grzyska, U., Kohlrusch, F. K., VON Kroge, S., Vollkommer, T. & Luebke, A. M., 06.2020, In: ANTICANCER RES. 40, 6, p. 3333-3343 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

    Fraune, C., Simon, R., Hube-Magg, C., Makrypidi-Fraune, G., Kähler, C., Kluth, M., Höflmayer, D., Büscheck, F., Dum, D., Luebke, A. M., Burandt, E., Clauditz, T. S., Wilczak, W., Sauter, G. & Steurer, S., 05.2020, In: UROL ONCOL-SEMIN ORI. 38, 5, p. 488-495 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma

    Jacobsen, F., Kohsar, J., Gebauer, F., Kluth, M., Hube-Magg, C., Simon, R., Bockhorn, M., Hinsch, A., Burandt, E., Lübke, A. M., Steurer, S., Tachezy, M., Sauter, G., Izbicki, J. R., Wilczak, W. & Melling, N., 24.03.2020, In: ONCOTARGET. 11, 12, p. 1007-1016 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

    Fraune, C., Harms, L., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Möller, K., Luebke, A. M., Möller-Koop, C., Steurer, S., Hube-Magg, C., Sauter, G., Weidemann, S., Lebok, P., Dum, D., Kind, S., Minner, S., Izbicki, J. R., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Schroeder, C., 06.03.2020, In: MOL MED. 26, 1, p. 24

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

    Kind, S., Kluth, M., Hube-Magg, C., Möller, K., Makrypidi-Fraune, G., Lutz, F., Lennartz, M., Rico, S. D., Schlomm, T., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Lübke, A. M., Simon, R., Sauter, G., Marx, A. & Polonski, A., 2020, In: BIOMED RES INT . 2020, p. 5845374

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

    Marx, A., Luebke, A. M., Clauditz, T. S., Steurer, S., Fraune, C., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Möller-Koop, C., Simon, R., Sauter, G., Göbel, C., Lebok, P., Dum, D., Kind, S., Minner, S., Izbicki, J., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Meiners, J., 2020, In: DIS MARKERS. 2020, p. 7050146

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2019

  22. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    Steurer, S., Schwemmer, L., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Luebke, A. M., Simon, R., Sauter, G., Izbicki, J., Schroeder, C., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Minner, S. & Meiners, J., 24.12.2019, In: ONCOTARGET. 10, 67, p. 7096-7111 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Symptomatic Mandibular Fibrous Dysplasia With Concurrent Triple X- and Premutation Stage Fragile-X-Syndrome: Case Report With Short Literature Survey

    Friedrich, R. E., Kohlrusch, F. K. & Luebke, A. M., 12.2019, In: ANTICANCER RES. 39, 12, p. 6769-6780 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  24. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

    Weidemann, S. A., Sauer, C., Luebke, A. M., Möller-Koop, C., Steurer, S., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Sauter, G., Göbel, C., Lebok, P., Dum, D., Fraune, C., Kind, S., Minner, S., Izbicki, J., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Heumann, A., 12.10.2019, In: BMC CANCER. 19, 1, p. 944

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula

    Priemel, M. H., Erler, J. M. E., Zustin, J., Luebke, A. M., Stiel, N. & Spiro, A. S., 10.2019, In: J BONE ONCOL. 18, p. 100258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

    Steurer, S., Hager, B., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Minner, S., Clauditz, T. S., Hube-Magg, C., Luebke, A. M., Simon, R., Izbicki, J. R., Burandt, E., Sauter, G., Fraune, C., Weidemann, S., Schlomm, T., Heinzer, H., Haese, A., Graefen, M., Huland, H. & Heumann, A., 25.09.2019, In: AGING-US. 11, 18, p. 7859-7879 21 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

    Bonk, S., Kluth, M., Hube-Magg, C., Polonski, A., Soekeland, G., Makropidi-Fraune, G., Möller-Koop, C., Witt, M., Luebke, A. M., Hinsch, A., Burandt, E., Steurer, S., Clauditz, T. S., Schlomm, T., Perez, D., Graefen, M., Heinzer, H., Huland, H., Izbicki, J. R., Wilczak, W., Minner, S., Sauter, G. & Simon, R., 10.09.2019, In: ONCOTARGET. 10, 52, p. 5439-5453 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

    Minner, S., Hager, D., Steurer, S., Höflmayer, D., Tsourlakis, M. C., Möller-Koop, C., Clauditz, T. S., Hube-Magg, C., Luebke, A. M., Simon, R., Sauter, G., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Izbicki, J., Burandt, E., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M. & Heumann, A., 09.2019, In: NEOPLASIA. 21, 9, p. 872-881 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

    Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., Simon, R., Büscheck, F., Luebke, A. M., Goebel, C., Lang, D. S., Weidemann, S., Neubauer, E., Hinsch, A., Jacobsen, F., Lebok, P., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Höflmayer, D., 13.08.2019, In: ONCOTARGET. 10, 48, p. 4973-4986 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 5q21 deletion is often heterogeneous in prostate cancer

    Kluth, M., Al Kilani, Z., Özden, C., Hussein, K., Frogh, S., Möller-Koop, C., Burandt, E., Steurer, S., Büscheck, F., Jacobsen, F., Luebke, A. M., Minner, S., Tsourlakis, M. C., Hoeflmayer, D., Wittmer, C., Schlomm, T., Sauter, G., Simon, R. & Wilczak, W., 08.2019, In: GENE CHROMOSOME CANC. 58, 8, p. 509-515 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Expression of the immune checkpoint receptor TIGIT in seminoma

    Hinsch, A., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S. & Wilczak, W., 08.2019, In: ONCOL LETT. 18, 2, p. 1497-1502 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S. & Minner, S., 07.2019, In: TUMOR BIOL. 41, 7, p. 1010428318824815

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Bone tumours of the clavicle: Histopathological, anatomical and epidemiological analysis of 113 cases

    Priemel, M. H., Stiel, N., Zustin, J., Luebke, A. M., Schlickewei, C. & Spiro, A. S., 06.2019, In: J BONE ONCOL. 16, p. 100229

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. SNW1 is a prognostic biomarker in prostate cancer

    Höflmayer, D., Willich, C., Hube-Magg, C., Simon, R., Lang, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Huland, H., Graefen, M., Haese, A., Heinzer, H., Minner, S., Büscheck, F., Sauter, G., Schlomm, T., Steurer, S., Clauditz, T. S., Burandt, E., Wilczak, W. & Bernreuther, C., 01.05.2019, In: DIAGN PATHOL. 14, 1, p. 33

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Implementation of a multidisciplinary infections conference affects the treatment plan in prosthetic joint infections of the hip:a retrospective study

    Ntalos, D., Berger-Groch, J., Rohde, H., Grossterlinden, L. G., Both, A., Luebke, A., Hartel, M. J. & Klatte, T. O., 04.2019, In: ARCH ORTHOP TRAUM SU. 139, 4, p. 467-473 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

    Kind, S., Merenkow, C., Büscheck, F., Möller, K., Dum, D., Chirico, V., Luebke, A. M., Höflmayer, D., Hinsch, A., Jacobsen, F., Göbel, C., Weidemann, S., Fraune, C., Möller-Koop, C., Hube-Magg, C., Clauditz, T. S., Simon, R., Sauter, G., Wilczak, W., Bawahab, A. A., Izbicki, J. R., Perez, D. & Marx, A., 2019, In: DIS MARKERS. 2019, 4928315.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2018

  42. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

    Kluth, M., Scherzai, S., Büschek, F., Fraune, C., Möller, K., Höflmayer, D., Minner, S., Göbel, C., Möller-Koop, C., Hinsch, A., Neubauer, E., Tsourlakis, M. C., Sauter, G., Heinzer, H., Graefen, M., Wilczak, W., Luebke, A. M., Burandt, E., Steurer, S., Schlomm, T. & Simon, R., 10.2018, In: GENE CHROMOSOME CANC. 57, 10, p. 504-512 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Growth of Cutibacterium acnes is common on osteosynthesis material of the shoulder in patients without signs of infection

    Both, A., Klatte, T. O., Lübke, A., Büttner, H., Hartel, M. J., Grossterlinden, L. G. & Rohde, H., 10.2018, In: ACTA ORTHOP. 89, 5, p. 580-584 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 21.08.2018, In: SCI REP-UK. 8, 1, p. 12821

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  46. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

    Hinsch, A., Brolund, M., Hube-Magg, C., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Steurer, S., Luebke, A., Angerer, A., Wittmer, C., Neubauer, E., Göbel, C., Büscheck, F., Minner, S., Wilczak, W., Schlomm, T., Jacobsen, F., Clauditz, T. S., Krech, T., Tsourlakis, M. C. & Schroeder, C., 06.2018, In: WORLD J UROL. 36, 6, p. 877-882 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Clinical and Microstructural Findings in Paget Disease of the Entire Mandible

    Friedrich, R. E., Luebke, A. M., Amling, M. & Koehne, T., 02.2018, In: J ORAL MAXIL SURG. 76, 2, p. 336-346 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

    Kluth, M., Volta, H., Hussein, M., Taskin, B., Frogh, S., Möller-Koop, C., Büscheck, F., Jacobsen, F., Tsourlakis, M. C., Lübke, A. M., Hinsch, A., Clauditz, T., Graefen, M., Heinzer, H., Huland, H., Minner, S., Sauter, G., Wilczak, W., Schlomm, T. & Simon, R., 2018, In: CANCER MANAG RES. 10, p. 5909-5917 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Upregulation of centromere protein F is linked to aggressive prostate cancers

    Göbel, C., Özden, C., Schroeder, C., Hube-Magg, C., Kluth, M., Möller-Koop, C., Neubauer, E., Hinsch, A., Jacobsen, F., Simon, R., Sauter, G., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T. & Luebke, A. M., 2018, In: CANCER MANAG RES. 10, p. 5491-5504 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 2017

  51. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    Tsourlakis, M. C., Eleftheriadou, A., Stender, A., Weigand, P., Grupp, K., Hube-Magg, C., Kluth, M., Schroeder, C., Steurer, S., Hinsch, A., Luebke, A., Angerer, A., Wittmer, C., Friedrich, E., Göbel, C., Büscheck, F., Heinzer, H., Graefen, M., Simon, R., Sauter, G., Wilczak, W., Minner, S., Schlomm, T. & Jacobsen, F., 07.12.2017, In: CARCINOGENESIS. 38, 12, p. 1180-1187 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion

    Juhnke, M., Heumann, A., Chirico, V., Höflmayer, D., Menz, A., Hinsch, A., Hube-Magg, C., Kluth, M., Lang, D. S., Möller-Koop, C., Sauter, G., Simon, R., Beyer, B., Pompe, R., Thederan, I., Schlomm, T. & Luebke, A. M., 09.2017, In: MOL CARCINOGEN. 56, 9, p. 2135-2145 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

    Jacobsen, F., Kraft, J., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Sauter, G., Izbicki, J. R., Clauditz, T. S., Luebke, A. M., Hinsch, A., Wilczak, W., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Melling, N., 09.2017, In: NEOPLASIA. 19, 9, p. 707-715 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 17.05.2017, In: SCI REP-UK. 7, 1, p. 2056

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

    Burdelski, C., Fitzner, M., Hube-Magg, C., Kluth, M., Heumann, A., Simon, R., Krech, T., Clauditz, T., Büscheck, F., Steurer, S., Wittmer, C., Hinsch, A., Luebke, A. M., Jacobsen, F., Minner, S., Tsourlakis, M. C., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Izbicki, J., Schlomm, T. & Wilczak, W., 04.2017, In: NEOPLASIA. 19, 4, p. 279-287 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next